sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered - United Kingdom
doi 10.1080/21655979.2019.1621136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology
Forensic MedicinePathology
2012English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Clinical Importance of S100A9 in Osteosarcoma Development and as a Diagnostic Marker and Therapeutic Target

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Stem Cells International
Cell BiologyMolecular Biology
2016English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Annexin A8 Can Serve as Potential Prognostic Biomarker and Therapeutic Target for Ovarian Cancer: Based on the Comprehensive Analysis of Annexins

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy